These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 36235011)
1. Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug-Protein Binding. Alamri MA; Tahir Ul Qamar M; Alabbas AB; Alqahtani SM; Alossaimi MA; Azam S; Hashmi MH; Rajoka MSR Molecules; 2022 Oct; 27(19):. PubMed ID: 36235011 [TBL] [Abstract][Full Text] [Related]
2. Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type. Mohammad A; Al-Mulla F; Wei DQ; Abubaker J Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206274 [TBL] [Abstract][Full Text] [Related]
3. Binding properties of selective inhibitors of P323L mutated RdRp of SARS-CoV-2: a combined molecular screening, docking and dynamics simulation study. Chinnamadhu A; Ramakrishnan J; Suresh S; Poomani K J Biomol Struct Dyn; 2024 May; 42(8):4283-4296. PubMed ID: 37301607 [TBL] [Abstract][Full Text] [Related]
4. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach. Dhankhar P; Dalal V; Kumar V J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746 [TBL] [Abstract][Full Text] [Related]
5. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. Lung J; Lin YS; Yang YH; Chou YL; Shu LH; Cheng YC; Liu HT; Wu CY J Med Virol; 2020 Jun; 92(6):693-697. PubMed ID: 32167173 [TBL] [Abstract][Full Text] [Related]
6. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation. Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630 [TBL] [Abstract][Full Text] [Related]
17. Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp. Murali M; Gowtham HG; Ansari MA; Alomary MN; Alghamdi S; Almehmadi M; Singh SB; Shilpa N; Aiyaz M; Kalegowda N; Ledesma AE; Amruthesh KN Curr Pharm Des; 2022; 28(12):969-980. PubMed ID: 35796443 [TBL] [Abstract][Full Text] [Related]
18. Remdesivir analogs against SARS-CoV-2 RNA-dependent RNA polymerase. Ahmed S; Mahtarin R; Islam MS; Das S; Al Mamun A; Ahmed SS; Ali MA J Biomol Struct Dyn; 2022; 40(21):11111-11124. PubMed ID: 34315339 [TBL] [Abstract][Full Text] [Related]
19. Novel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective. Alrehaily A; Elfiky AA; Ibrahim IM; Ibrahim MN; Sonousi A Sci Rep; 2023 Dec; 13(1):23080. PubMed ID: 38155165 [TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target. Yashvardhini N; Jha DK; Bhattacharya S Arch Microbiol; 2021 Nov; 203(9):5463-5473. PubMed ID: 34410443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]